Strategic Alliance Between UndoAge and Novonesis to Enhance Probiotics in China
In a significant move aimed at transforming the probiotics landscape in China, UndoAge and Novonesis, a leading global biosolutions provider supported by Novo Holdings, have entered into a strategic partnership. This collaboration was formalized through a Memorandum of Understanding signed in Beijing on June 9, 2026. The primary goal of this alliance is to deepen exploration and development in probiotics and microbiome health, particularly focusing on rapidly growing consumer segments such as stomach health, digestive wellness, and women’s intimate health.
Collaboration Objectives
This partnership is designed to harness the unique strengths of both companies through innovation, ingredient technology, and market service collaboration. By combining efforts, UndoAge and Novonesis aim to not only elevate the standards of probiotic products available in China but also to provide consumers with scientifically validated health solutions that are both transparent and reliable.
Meeting Consumer Demands for Health Products
As the Chinese government promotes its national strategy for a 'Healthy China', public interest in personal health and wellness products is rapidly escalating. The demand for probiotics is expanding beyond traditional gut health benefits. This increasing consumer awareness concerning health and nutrition is leading to a diversified market where probiotics serve various purposes, including gastric wellness, women’s health, and overall immune support. Novonesis—formally a result of the merger between two notable biotech firms, Novozymes and Chr. Hansen—brings substantial expertise in microbiome science, clinical research, and the development of probiotic strains. Conversely, UndoAge specializes in consumer health initiatives aimed at providing science-oriented nutritional solutions for a worldwide clientele, with a particular emphasis on addressing the evolving needs of the Chinese customer.
Innovative Product Lines
Under the terms of the MOU, UndoAge and Novonesis will collaborate to accelerate the introduction of Novonesis's proprietary probiotic strains and solutions specifically in the consumer health sector of China. Their initial focus will center on two innovative product categories:
1. Pylopass™-based postbiotic products tailored to enhance stomach health and support digestive wellness;
2. Urex™-based probiotic products designed for improving women's microbiome health, thereby addressing the specific wellness requirements of female consumers.
Both companies aim to leverage Novonesis's technical proficiency and research depth in probiotics, alongside UndoAge's understanding of consumer trends in China, to ensure the resulting products are not only scientifically valid but also cater effectively to market needs.
Enhancing Transparency and Quality in the Industry
The agreement underscores a significant trend within the probiotics sector, moving from a purely marketing-driven approach to one that prioritizes scientific integrity and quality assurance. In this partnership, UndoAge will strengthen its affiliations with research institutions and ingredient suppliers to boost transparency and product standardization in development processes. Novonesis will lend its expertise in microbial R&D and formulation support, laying a solid scientific foundation for collaborative products.
As this partnership evolves, both parties are poised to explore more opportunities in product development, technology sharing, and science communication, with a dedicated focus on enhancing consumer understanding of strain traceability, scientific backing, and rigorous quality management systems.
Leadership Insights on the Future of Health Products
Dr. Zhou Jin, who heads Human Health Biosolutions at Novonesis, remarked on the potential of the Chinese health market and the timely need for more professionally curated, scientifically validated probiotic options. Meanwhile, Zhu Xiaomu, the founder and CEO of UndoAge, emphasized their commitment to centering consumer needs in their product offerings and their pursuit of excellence in health solutions by collaborating with global leaders in research and ingredient supply.
Conclusion
As the probiotics sector in China transitions into a more scientifically oriented and quality-focused market, this partnership signifies a pivotal step towards aligning premium scientific expertise with consumer demand. UndoAge and Novonesis are positioned to not only enhance the quality and standardization of probiotic products but also promote consumer trust and awareness in the realm of health and nutrition. Together, they aim to pave the way for the future of probiotics in China, moving towards a market that values scientific evidence and integrity as the cornerstone of consumer health products.
Collaboration Objectives
This partnership is designed to harness the unique strengths of both companies through innovation, ingredient technology, and market service collaboration. By combining efforts, UndoAge and Novonesis aim to not only elevate the standards of probiotic products available in China but also to provide consumers with scientifically validated health solutions that are both transparent and reliable.
Meeting Consumer Demands for Health Products
As the Chinese government promotes its national strategy for a 'Healthy China', public interest in personal health and wellness products is rapidly escalating. The demand for probiotics is expanding beyond traditional gut health benefits. This increasing consumer awareness concerning health and nutrition is leading to a diversified market where probiotics serve various purposes, including gastric wellness, women’s health, and overall immune support. Novonesis—formally a result of the merger between two notable biotech firms, Novozymes and Chr. Hansen—brings substantial expertise in microbiome science, clinical research, and the development of probiotic strains. Conversely, UndoAge specializes in consumer health initiatives aimed at providing science-oriented nutritional solutions for a worldwide clientele, with a particular emphasis on addressing the evolving needs of the Chinese customer.
Innovative Product Lines
Under the terms of the MOU, UndoAge and Novonesis will collaborate to accelerate the introduction of Novonesis's proprietary probiotic strains and solutions specifically in the consumer health sector of China. Their initial focus will center on two innovative product categories:
1. Pylopass™-based postbiotic products tailored to enhance stomach health and support digestive wellness;
2. Urex™-based probiotic products designed for improving women's microbiome health, thereby addressing the specific wellness requirements of female consumers.
Both companies aim to leverage Novonesis's technical proficiency and research depth in probiotics, alongside UndoAge's understanding of consumer trends in China, to ensure the resulting products are not only scientifically valid but also cater effectively to market needs.
Enhancing Transparency and Quality in the Industry
The agreement underscores a significant trend within the probiotics sector, moving from a purely marketing-driven approach to one that prioritizes scientific integrity and quality assurance. In this partnership, UndoAge will strengthen its affiliations with research institutions and ingredient suppliers to boost transparency and product standardization in development processes. Novonesis will lend its expertise in microbial R&D and formulation support, laying a solid scientific foundation for collaborative products.
As this partnership evolves, both parties are poised to explore more opportunities in product development, technology sharing, and science communication, with a dedicated focus on enhancing consumer understanding of strain traceability, scientific backing, and rigorous quality management systems.
Leadership Insights on the Future of Health Products
Dr. Zhou Jin, who heads Human Health Biosolutions at Novonesis, remarked on the potential of the Chinese health market and the timely need for more professionally curated, scientifically validated probiotic options. Meanwhile, Zhu Xiaomu, the founder and CEO of UndoAge, emphasized their commitment to centering consumer needs in their product offerings and their pursuit of excellence in health solutions by collaborating with global leaders in research and ingredient supply.
Conclusion
As the probiotics sector in China transitions into a more scientifically oriented and quality-focused market, this partnership signifies a pivotal step towards aligning premium scientific expertise with consumer demand. UndoAge and Novonesis are positioned to not only enhance the quality and standardization of probiotic products but also promote consumer trust and awareness in the realm of health and nutrition. Together, they aim to pave the way for the future of probiotics in China, moving towards a market that values scientific evidence and integrity as the cornerstone of consumer health products.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.